ZBH logo

Zimmer Biomet Holdings Stock Price

Symbol: NYSE:ZBHMarket Cap: US$20.4bCategory: Healthcare

ZBH Share Price Performance

US$102.56
-9.21 (-8.24%)
7.5% undervalued intrinsic discount
US$110.92
Fair Value
US$102.56
-9.21 (-8.24%)
7.5% undervalued intrinsic discount
US$110.92
Fair Value
Price US$102.56
AnalystConsensusTarget US$110.92

ZBH Community Narratives

AnalystConsensusTarget·Updated
Fair Value US$110.92 7.5% undervalued intrinsic discount

Aging Population And Robotics Will Elevate Orthopedic Care

0users have liked this narrative
0users have commented on this narrative
23users have followed this narrative

Recent ZBH News & Updates

Here's Why Zimmer Biomet Holdings (NYSE:ZBH) Can Manage Its Debt Responsibly

Jul 22
Here's Why Zimmer Biomet Holdings (NYSE:ZBH) Can Manage Its Debt Responsibly

Many Still Looking Away From Zimmer Biomet Holdings, Inc. (NYSE:ZBH)

Jul 04
Many Still Looking Away From Zimmer Biomet Holdings, Inc. (NYSE:ZBH)

Zimmer Biomet Holdings (NYSE:ZBH) Is Paying Out A Dividend Of $0.24

Jun 16
Zimmer Biomet Holdings (NYSE:ZBH) Is Paying Out A Dividend Of $0.24

Zimmer Biomet Holdings' (NYSE:ZBH) Dividend Will Be $0.24

Jun 02
Zimmer Biomet Holdings' (NYSE:ZBH) Dividend Will Be $0.24

Zimmer Biomet Holdings (NYSE:ZBH) Shareholders Will Want The ROCE Trajectory To Continue

May 27
Zimmer Biomet Holdings (NYSE:ZBH) Shareholders Will Want The ROCE Trajectory To Continue

Zimmer Biomet Holdings, Inc. Key Details

US$7.8b

Revenue

US$2.3b

Cost of Revenue

US$5.6b

Gross Profit

US$4.8b

Other Expenses

US$823.5m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
Earnings per share (EPS)
4.16
Gross Margin
71.25%
Net Profit Margin
10.51%
Debt/Equity Ratio
61.6%

Zimmer Biomet Holdings, Inc. Competitors

 
 
 
 
 
 
 
 
 
 
 
 
This week, we’re going to look at the U.S. regulatory changes, how adoption has been trending, and one of the risks with the ETFs. If you want some exposure to Bitcoin, at the end, we’ll show you some different ways you can position your portfolio accordingly.
Continue reading

About ZBH

Founded
1927
Employees
17000
CEO
Ivan Tornos
WebsiteView website
www.zimmerbiomet.com

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It offers technology and data, bone cement, and surgical products. The company’s products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

U.S. Market Performance

  • 7 Days: 1.3%
  • 3 Months: 8.8%
  • 1 Year: 15.8%
  • Year to Date: 9.5%
The Healthcare and Consumer Discretionary sectors drove a 1.3% in the market over the last week. As for the past 12 months, the market is up 16%. Earnings are forecast to grow by 15% annually. Market details ›